美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

百济神州

294.55

+4.201.45%

盘后：294.550.00000.00%19:56 EDT

成交量：89.35万

成交额：2.65亿

市值：348.90亿

市盈率：-79.54

高：300.00

开：297.50

低：293.51

收：290.35

数据加载中...

总览公司新闻公告

创新药的天是晴朗的天

财富观察室

深夜！美国重磅数据发布！特朗普：没军队帮忙，洛杉矶将成“犯罪现场”

百济神州在2025年欧洲血液学协会年会上展示CLL和MCL治疗领域的突破性临床试验数据

车企60天账期承诺之下，汽车芯片供应商有何利好？

继续爆发！最强霸榜板块

百济神州“泽布替尼片剂”在美国获批上市

医药魔方Info

创新药概念再度拉升百济神州涨超7%创历史新高

南方财经网

百济神州6月11日成交额为7379.23万美元

跟踪 |【瑞银】2025年创新药行情全解析

思维纪要社

百济神州“翻盘”：11年烧掉近600亿，凭一款爆品药或将迎来首个盈利年

百济神州6月10日成交额为1.09亿美元

AMAC医药制造指数上涨0.64%，前十大权重包含百济神州等

创新药+新消费正成投资新主线

百济神州6月9日成交额为1.29亿美元

美股异动 | 百济神州(ONC.US)涨逾4% 机构：创新药有望迎来价值重估

百济神州预期乐观背后，产业领域创新接二连三受到挫折

百济神州更名BeOne并迁址瑞士

Ofweek光电信息网

百济神州6月5日成交额为3977.19万美元

@望京博格：欧美医药企业有很多市值超万亿，中国药企只有恒瑞医药、百济神州超3000亿元，未来成长空间很大

百济神州6月4日成交额为7447.90万美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ONC/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":294.55,"timestamp":1752868800000,"preClose":290.35,"halted":0,"volume":893526,"hourTrading":{"tag":"盘后","latestPrice":294.55,"preClose":294.55,"latestTime":"19:56 EDT","volume":2550,"amount":751110.08,"timestamp":1752883001543},"delay":0,"floatShares":75541600,"shares":118450658,"eps":-3.70325,"marketStatus":"休市中","change":4.2,"latestTime":"07-18 16:00:00 EDT","open":297.5,"high":300,"low":293.51,"amount":264758392.69818002,"amplitude":0.022352,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.70325,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":290.35,"preHourTrading":{"tag":"盘前","latestPrice":299.25,"preClose":290.35,"latestTime":"09:29 EDT","volume":3281,"amount":982962.59878,"timestamp":1752845389593},"postHourTrading":{"tag":"盘后","latestPrice":294.55,"preClose":294.55,"latestTime":"19:56 EDT","volume":2550,"amount":751110.08,"timestamp":1752883001543},"volumeRatio":1.826344,"impliedVol":0.5068,"impliedVolPercentile":0.8519},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":75541600,"roa":"-3.22%","roe":"-11.44%","lyrEps":-6.124009,"volumeRatio":1.826344,"shares":118450658,"dividePrice":0,"high":300,"amplitude":0.022352,"preClose":290.35,"low":293.51,"week52Low":148.81,"pbRate":"9.97","psRate":"8.36","week52High":300,"institutionHeld":0,"latestPrice":294.55,"eps":-3.70325,"divideRate":0,"volume":893526,"delay":0,"ttmEps":-3.70325,"open":297.5,"prevYearClose":184.71,"prevWeekClose":250.3,"prevMonthClose":242.07,"prevQuarterClose":242.07,"fiveDayClose":250.3,"twentyDayClose":252.78,"sixtyDayClose":252.77},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543521315","title":"创新药的天是晴朗的天","url":"https://stock-news.laohu8.com/highlight/detail?id=2543521315","media":"财富观察室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543521315?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 09:01","pubTimestamp":1749776494,"startTime":"0","endTime":"0","summary":"截至6月9日，恒生创新药指数年内上涨61.53%，领涨行业指数。创新药涨得猛，核心原因是它业绩的确很能打。在这种情况下，投资创新药企业的收益也会是可观的。在一季报中，他明确指出，“创新药板块迎来三端共振、类比此前中国新能源汽车板块的崛起”。在中国创新药突破、医药行业回暖的过程中，桑翔宇主攻创新药、刘潇板块内轮动的做法，都值得重点关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613090356a4a6341d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613090356a4a6341d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4550","ONC","01801","01093","688235","BK4526","FDN","BK4588","06160","BK4139","09926"],"gpt_icon":0},{"id":"2542548998","title":"深夜！美国重磅数据发布！特朗普：没军队帮忙，洛杉矶将成“犯罪现场”","url":"https://stock-news.laohu8.com/highlight/detail?id=2542548998","media":"e公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542548998?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 22:38","pubTimestamp":1749739132,"startTime":"0","endTime":"0","summary":"美国重磅数据发布消息面上，美国5月PPI同比增长2.6%，符合预期，前值增长2.4%。特朗普：没军队帮忙，洛杉矶将成“犯罪现场”据央视新闻，美国总统特朗普12日在其社交媒体平台“真实社交”上再次就洛杉矶局势表态。特朗普说，过去两晚，洛杉矶平安无事，美国国民警卫队与海军陆战队的帮助使洛杉矶警方能够有效地履行职责。特朗普称，如果没有军队的帮助，洛杉矶将会变成“多年未见的犯罪现场”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612224507a70585cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612224507a70585cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","LU0157215616.USD","LU0738911758.USD","BK4551","LU1934455277.USD","LU1815336760.USD","LU1935043536.SGD","IE00BBT3K403.USD","LU0719512351.SGD","LU0320765489.SGD","IE0004445239.USD","LU0661504455.SGD","LU0949170772.SGD","LU1366333091.USD","LU0208291251.USD","LU0198837287.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1935042991.SGD","BK4564","IE00B3S45H60.SGD","LU2054465674.USD","LU0323591593.USD","LU0109392836.USD","LU0348723411.USD","IE00B5949003.HKD","IE00B775SV38.USD","LU1935042215.USD","IE00B19Z3581.USD","BK4533","BK4543","BK4538","IE00BLSP4239.USD","LU0980610538.SGD","IE00BLSP4452.SGD","LU2360106780.USD","LU0070302665.USD","LU1989764664.SGD","LU1852331112.SGD","LU0861579265.USD","LU1435385759.SGD","BK4528","LU1935042488.USD","LU0444973449.USD","IE00B7SZLL34.SGD","BK4534","LU1506573853.SGD","ORCL","LU1989764748.USD"],"gpt_icon":1},{"id":"2542515999","title":"百济神州在2025年欧洲血液学协会年会上展示CLL和MCL治疗领域的突破性临床试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2542515999","media":"百济神州","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542515999?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 18:14","pubTimestamp":1749723253,"startTime":"0","endTime":"0","summary":"EHA 2025年会上展示的数据支持将索托克拉和BGB-16673推进至3期研究，并为百济神州该部分项目首次药政递交奠定了基础。索托克拉联用百悦泽展示了在CLL和MCL患者中的深度缓解数据将彰显百济神州新一代产品的潜力，解决B细胞恶性肿瘤患者亟待满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612185718a705282a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612185718a705282a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK4139","06160","BK4526","ONC"],"gpt_icon":0},{"id":"2542518465","title":"车企60天账期承诺之下，汽车芯片供应商有何利好？","url":"https://stock-news.laohu8.com/highlight/detail?id=2542518465","media":"21ic电子网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542518465?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 18:04","pubTimestamp":1749722681,"startTime":"0","endTime":"0","summary":"芯片作为汽车电子电气系统的重要组成部分，汽车企业们整齐划一“60天账期承诺”的消息在半导体业内也引发广泛关注。汽车企业的“60天账期”承诺宣告后，也受到行业内外人士的质疑，比如：是否下线结算，再核对数量，核对完成下月开票，再给各商业汇票或者银行承兑90-180天。60天账期下，车企可能会转向更稳定的合作关系，为供应商提供明确订单预期，支持芯片的产能规划和技术迭代。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612182233a7051962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612182233a7051962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","BK4099","09868","BK4555","688235","EVS.SI","XPEV","09863","BK4526","BK4551","80175","BK4585","BK4588","ONC","02015","LI","BK4563","BK4548","BK4503","82333"],"gpt_icon":1},{"id":"2542588591","title":"继续爆发！最强霸榜板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2542588591","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542588591?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 17:03","pubTimestamp":1749718989,"startTime":"0","endTime":"0","summary":"要说今年的最强主线，创新药一定榜上有名。虽然昨天有过回撤，但一天的快速盘整后，今天继续称霸ETF涨幅榜。若美联储重启降息周期，将利好创新药板块的估值继续修复。创新药本就是目前股市中最热门的板块，没有之一，尤其是港股。这是自2020年10月28日以来，港元首次触发联系汇率机制下的强方兑换保证。6月7日，香港交易所公布每月市场概况。这种态势，预计还会继续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061217041395193abc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061217041395193abc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","688271","06160","688617","ONC","688578","399300","BK0239","159982"],"gpt_icon":0},{"id":"2542599125","title":"百济神州“泽布替尼片剂”在美国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2542599125","media":"医药魔方Info","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542599125?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 16:40","pubTimestamp":1749717634,"startTime":"0","endTime":"0","summary":"6月10日，FDA官网显示，百济神州的泽布替尼片剂获批上市。至此，泽布替尼已有胶囊和片剂两种剂型在美国获批上市。2019年11月，泽布替尼胶囊首次在美国获批上市，用于治疗套细胞淋巴瘤。据百济神州财报，2024年泽布替尼胶囊全球销售额为26.44亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612165009a704e360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612165009a704e360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4526","688235","ONC","06160"],"gpt_icon":0},{"id":"2542697885","title":"创新药概念再度拉升 百济神州涨超7%创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2542697885","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542697885?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 13:25","pubTimestamp":1749705923,"startTime":"0","endTime":"0","summary":"创新药概念再度拉升，百济神州涨超7%，再创历史新高，此前奥赛康涨停，荣昌生物、睿智医药、博瑞医药涨超10%，海思科、舒泰神、万邦德等多股涨超5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506123428808459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","06978","LU0307460666.USD","LU2328871848.SGD","BK1583","LU0588546209.SGD","06160","BK1161","LU1969619763.USD","BK1588","BK1574","BK4139","BK4526","BK1500"],"gpt_icon":0},{"id":"2542169565","title":"百济神州6月11日成交额为7379.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542169565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542169565?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 11:59","pubTimestamp":1749700762,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，百济神州成交额为7379.23万美元，成交额较昨日减少32.52%，当日成交量为28.26万股。百济神州于2025年6月11日跌0.38%，报262.41美元，该股过去5个交易日涨1.6%，年初至今涨42.07%，过去60日跌1.0%。百济神州有自己的团队进行全球临床试验。截至2023年，百济神州的核心药物是百悦泽，这是一种治疗各种血癌的小分子药物，占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612115926a7048873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612115926a7048873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONC","BK4526"],"gpt_icon":0},{"id":"2542306606","title":"跟踪 |【瑞银】2025年创新药行情全解析","url":"https://stock-news.laohu8.com/highlight/detail?id=2542306606","media":"思维纪要社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542306606?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 16:12","pubTimestamp":1749629565,"startTime":"0","endTime":"0","summary":"今年创新药行情的上涨可以分为三个阶段。其中约80%集中在肿瘤领域，55%属于双抗ADC领域，且大部分为早期产品。我们预计今年下半年可能会陆陆续续有一些POC的data出现，但其销售受到海外降药价影响的具体情况仍有待观察。康方的AK112在首次全球试验中的数据并不理想，但公司仍计划基于现有数据向FDA提交申报。SKB264作为首个完整商业化年度的ADC药物，预计销售额将在8亿到10亿人民","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611162235a70357b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611162235a70357b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK1161","600276","ONC","01276","01801","06160","06978","BK1574","BK1191"],"gpt_icon":1},{"id":"2542030331","title":"百济神州“翻盘”：11年烧掉近600亿，凭一款爆品药或将迎来首个盈利年","url":"https://stock-news.laohu8.com/highlight/detail?id=2542030331","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542030331?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 15:42","pubTimestamp":1749627731,"startTime":"0","endTime":"0","summary":"百济神州，这家被称为“烧钱一哥”的企业，在历经11年、累计亏损近600亿元之后，终于走到了盈亏的分水岭。泽布替尼爆发，百亿级营收撑起扭亏希望百济神州实现逆转的关键，在于一款爆品药物——泽布替尼。最关键的是，2021年百济神州发起了震动全球的一场“头对头”临床试验，将泽布替尼与伊布替尼直接PK。百济神州的逆袭，并不意味着烧钱模式的终结。百济神州的故事，是中国创新药企从“讲概念”走向“讲业绩”的一个缩影。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1749437338684780936","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06160","BK4139","BK1583","LU0588546209.SGD","LU2328871848.SGD","BK4526","BK1588","ONC","BK1500","LU1969619763.USD","BK1161","LU0307460666.USD"],"gpt_icon":0},{"id":"2542737515","title":"百济神州6月10日成交额为1.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542737515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542737515?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 11:42","pubTimestamp":1749613372,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，百济神州成交额为1.09亿美元，成交额较昨日减少15.03%，当日成交量为41.62万股。百济神州于2025年6月10日跌0.14%，报263.42美元，该股过去5个交易日涨4.65%，年初至今涨42.61%，过去60日涨1.63%。百济神州有自己的团队进行全球临床试验。截至2023年，百济神州的核心药物是百悦泽，这是一种治疗各种血癌的小分子药物，占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611114301a4a2db59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611114301a4a2db59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","BK4526","BK4139"],"gpt_icon":0},{"id":"2542343192","title":"AMAC医药制造指数上涨0.64%，前十大权重包含百济神州等","url":"https://stock-news.laohu8.com/highlight/detail?id=2542343192","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542343192?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 22:38","pubTimestamp":1749566332,"startTime":"0","endTime":"0","summary":"金融界6月10日消息，上证指数高开低走，AMAC医药制造指数 上涨0.64%，报4507.44点，成交额1008.07亿元。数据统计显示，AMAC医药制造指数近一个月上涨10.73%，近三个月上涨13.98%，年至今上涨13.45%。从指数持仓来看，AMAC医药制造指数十大权重分别为：恒瑞医药、片仔癀、云南白药、科伦药业、长春高新、新和成、复星医药、常山药业、上海莱士、百济神州。从AMAC医药制造指数持仓样本的行业来看，医药卫生占比98.09%、主要消费占比1.91%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/10223850989112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ONC","LU2328871848.SGD","BK0239","LU0307460666.USD","159938","BK1574","BK4526","688235","BK1583","BK1515","09939","BK1588","LU0588546209.SGD","06160","BK4139","399233","BK1500","BK1161","LU1969619763.USD"],"gpt_icon":0},{"id":"2542397468","title":"创新药+新消费正成投资新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2542397468","media":"红刊财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542397468?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 17:40","pubTimestamp":1749548400,"startTime":"0","endTime":"0","summary":"从产业角度看，在今年已经召开的两次国际学术大会上，多家内地的创新药企成为主角，展示了在研成果，从而让世界看到了中国创新药企的雄厚实力。从长期视角来看，创新药的研发突破与新消费品牌的崛起，正成为驱动中国资本市场高质量发展的双引擎。而在政策与产业共振下，基本面优质的创新药和新消费龙头公司，有望为投资者带来丰厚的回报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610174246a4a1b8fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610174246a4a1b8fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","688235","601579","688506","BK0196","LU2488822045.USD","159992","LU1064131003.USD","LU1064130708.USD","LU1328615791.USD","LU2148510915.USD","600276","BK0060","BK0028","LU0405327148.USD","LU0405327494.USD","BK0012","09992","ONC","BK0239","BK0183","LU2328871848.SGD","BK0188"],"gpt_icon":0},{"id":"2542655403","title":"百济神州6月9日成交额为1.29亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542655403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542655403?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 11:35","pubTimestamp":1749526528,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日，百济神州成交额为1.29亿美元，成交额较昨日增加25.21%，当日成交量为48.60万股。百济神州于2025年6月9日涨3.1%，报263.78美元，该股过去5个交易日涨7.26%，年初至今涨42.81%，过去60日涨3.62%。百济神州有自己的团队进行全球临床试验。截至2023年，百济神州的核心药物是百悦泽，这是一种治疗各种血癌的小分子药物，占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610113534a7018034&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610113534a7018034&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","BK4526","BK4139"],"gpt_icon":0},{"id":"2542338986","title":"美股异动 | 百济神州(ONC.US)涨逾4% 机构：创新药有望迎来价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338986","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542338986?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 21:59","pubTimestamp":1749477574,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，百济神州(ONC.US)涨逾4%，报267.04美元。消息面上，近期，ASCO正式召开，ASCO是全球肿瘤学领域规模最大、学术影响力最高的会议。ASCO报告上展示信达生物的IBI363(PD-1/IL2α双抗)在结直肠癌和IO经治非小细胞肺癌上展现出优异疗效，同时泽璟制药ZG005治疗宫颈癌数据、荣昌生物的RC108(c-MET ADC)等也有较好的数据展示。兴业证券表示，中国创新药具备高效率、低成本的开发优势，当前在热门技术赛道如ADC、双抗、细胞治疗等已经具备竞争优势，有望持续展现行业竞争力。机构分析认为，展望未来，创新药有望迎来价值重估。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1303170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1500","159992","BK1574","ONC","BK4526","LU2328871848.SGD","LU0307460666.USD","BK1588","06978","BK1161","BK1583","688235","BK4139","LU1969619763.USD","LU0588546209.SGD","06160"],"gpt_icon":0},{"id":"2542990801","title":"百济神州预期乐观背后，产业领域创新接二连三受到挫折","url":"https://stock-news.laohu8.com/highlight/detail?id=2542990801","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542990801?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 16:26","pubTimestamp":1749457565,"startTime":"0","endTime":"0","summary":"再次卷入诉讼纠纷、产业领域创新接连受挫近几年凭借泽布替尼风光无限的百济神州，去年以来在医药圈的产业领域遭遇到接二连三的打击。4月3日，百济神州宣布停止其投入近21亿元的TIGIT抗体Ociperlimab肺癌临床开发计划。截至2024年上半年，百济神州为研发该项目已累计投入20.9亿元。此前，双方已因血癌治疗药物专利纠纷对簿公堂。不过百济神州还有后手。对百济神州的未来发展情况，本刊将继续予以关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609163207a4a00a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609163207a4a00a4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","06160","688235","BK0239"],"gpt_icon":1},{"id":"2542105873","title":"百济神州更名BeOne并迁址瑞士","url":"https://stock-news.laohu8.com/highlight/detail?id=2542105873","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542105873?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 09:42","pubTimestamp":1749433320,"startTime":"0","endTime":"0","summary":"5月27日，百济神州宣布其新英文名称BeOne Medicines Ltd.正式启用，取代原来的BeiGene；注册地从开曼迁址瑞士；自存续注册生效日起，公司适用根据瑞士法律制定的公司章程。迁址后，百济神州“是一家注册地位于瑞士的全球肿瘤治疗创新公司，专注于为全世界的癌症患者研发创新抗肿瘤药物”。不过这一路线也导致其持续巨亏，截至2024年6月30日，百济神州累计未弥补亏损达605.66亿元。百济神州在公告中表示，该决策符合公司股东最佳利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060909510397771332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060909510397771332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU2328871848.SGD","688235","BK1583","LU0307460666.USD","BK1588","BK1161","LU1969619763.USD","ONC","BK1500","LU0588546209.SGD"],"gpt_icon":0},{"id":"2541081881","title":"百济神州6月5日成交额为3977.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541081881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541081881?lang=zh_cn&edition=fundamental","pubTime":"2025-06-06 11:46","pubTimestamp":1749181591,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，百济神州成交额为3977.19万美元，成交额较昨日减少46.60%，当日成交量为15.44万股。百济神州于2025年6月5日跌0.49%，报257.0美元，该股过去5个交易日涨4.18%，年初至今涨39.14%，过去60日涨4.59%。百济神州有自己的团队进行全球临床试验。截至2023年，百济神州的核心药物是百悦泽，这是一种治疗各种血癌的小分子药物，占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606114632a49c4fd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606114632a49c4fd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4526","ONC"],"gpt_icon":0},{"id":"2541025830","title":"@望京博格：欧美医药企业有很多市值超万亿，中国药企只有恒瑞医药、百济神州超3000亿元，未来成长空间很大","url":"https://stock-news.laohu8.com/highlight/detail?id=2541025830","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541025830?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 17:02","pubTimestamp":1749114120,"startTime":"0","endTime":"0","summary":"6月5日消息，知名基金博主@望京博格 表示，欧美医药企业有很多市值超过万亿， 中国药企只有恒瑞医药、百济神州超3000亿元，药明康德、瀚森制药、信达生物也只是刚刚迈过千亿市值门槛。中国药企与全球大药企的市值相比天壤之别，这也是未来的成长空间。@望京博格 认为，创新药毛利率很高，不比新能源汽车出口赚的少，这是一个非常大的市场。\n　　以下是全文：\n\n\nMACD金叉信号形成，这些股涨势不错！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：常福强","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-06-05/doc-ineyzhci6455321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0588546209.SGD","LU0405327148.USD","600276","BK0188","BK0183","688235","BK1191","LU2328871848.SGD","BK0028","LU1064130708.USD","LU1328615791.USD","BK1161","LU2148510915.USD","BK1588","LU1969619763.USD","LU0307460666.USD","01276","BK0060","06160","LU1064131003.USD","LU0405327494.USD","LU2488822045.USD","BK1583","BK1500","ONC","BK0239","BK0012","BK0196","BK4139","BK4526"],"gpt_icon":0},{"id":"2541012417","title":"百济神州6月4日成交额为7447.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541012417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541012417?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 11:41","pubTimestamp":1749094887,"startTime":"0","endTime":"0","summary":"美东时间2025年6月4日，百济神州成交额为7447.90万美元，成交额较昨日增加13.75%，当日成交量为28.78万股。百济神州于2025年6月4日涨2.6%，报258.27美元，该股过去5个交易日涨7.43%，年初至今涨39.82%，过去60日涨6.43%。百济神州有自己的团队进行全球临床试验。截至2023年，百济神州的核心药物是百悦泽，这是一种治疗各种血癌的小分子药物，占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605114135a6fb20f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605114135a6fb20f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONC","BK4526"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"盘前","dateTimestamp":1756526400000,"actualEps":null},{"market":"US","date":"2025-05-07","symbol":"ONC","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":1.22},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3182,"buy":0.6364,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":22,"updateTime":1748318400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-07-17","current":-84.275105,"percent":0.021127,"low":-89.808695,"twenty":-47.010053,"median":-39.274234,"eighty":-23.175318,"high":-19.234246,"avg":-40.083783,"sd":18.230961,"marketCap":33066685687},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-17","current":-84.275105,"twenty":-47.010053,"median":-39.274234,"eighty":-23.175318,"marketCap":33066685687}],"updateTime":1752893617598}}}